Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada
· Delayed Price · Currency is CAD 18.28
-0.23 (-1.24%)
Apr 28, 2026, 4:00 PM EST
Cipher Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 27.33 | 11.55 | 20.38 | 26.64 | 7.76 | Upgrade
|
| Depreciation & Amortization | 7.22 | 4.02 | 1.23 | 0.99 | 0.7 | Upgrade
|
| Other Amortization | 0.16 | 0.06 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | - | - | - | 0.76 | Upgrade
|
| Stock-Based Compensation | 1.74 | 1.07 | 1.19 | 0.4 | 0.14 | Upgrade
|
| Other Operating Activities | -11.82 | -6.1 | -3.53 | -14.27 | -0.22 | Upgrade
|
| Change in Accounts Receivable | 2.65 | -8.77 | 1.71 | -0.14 | 2.56 | Upgrade
|
| Change in Inventory | -2.4 | 3.6 | -0.83 | -0.5 | -0.76 | Upgrade
|
| Change in Accounts Payable | 0.52 | 1.28 | 0.53 | -1.45 | -1.23 | Upgrade
|
| Change in Unearned Revenue | 5.02 | 12.79 | 0.27 | -0.19 | 0.14 | Upgrade
|
| Change in Income Taxes | -0.05 | 0.05 | -4.97 | -0.85 | 3.59 | Upgrade
|
| Change in Other Net Operating Assets | -0.52 | 0.01 | 0.01 | 0.1 | 0.37 | Upgrade
|
| Operating Cash Flow | 29.73 | 19.55 | 16 | 10.73 | 13.81 | Upgrade
|
| Operating Cash Flow Growth | 52.08% | 22.17% | 49.18% | -22.36% | 18.17% | Upgrade
|
| Capital Expenditures | -0.03 | -80.04 | -0.14 | -0.08 | - | Upgrade
|
| Sale of Property, Plant & Equipment | 0.13 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.17 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.07 | -80.04 | -0.14 | -0.08 | - | Upgrade
|
| Long-Term Debt Issued | - | 40 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -35.31 | -0.23 | -0.11 | -0.06 | -0.83 | Upgrade
|
| Net Debt Issued (Repaid) | -35.31 | 39.77 | -0.11 | -0.06 | -0.83 | Upgrade
|
| Issuance of Common Stock | 0.22 | 0.15 | 0.43 | 0.13 | 0.08 | Upgrade
|
| Repurchase of Common Stock | -5.38 | -0.18 | -5.56 | -1.99 | -1.72 | Upgrade
|
| Other Financing Activities | - | -0.45 | - | - | - | Upgrade
|
| Financing Cash Flow | -40.47 | 39.3 | -5.24 | -1.91 | -2.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.47 | -0.79 | 0.38 | -0.44 | 0.06 | Upgrade
|
| Net Cash Flow | -10.34 | -21.99 | 10.99 | 8.29 | 11.41 | Upgrade
|
| Free Cash Flow | 29.7 | -60.5 | 15.86 | 10.64 | 13.81 | Upgrade
|
| Free Cash Flow Growth | - | - | 48.96% | -22.95% | 18.27% | Upgrade
|
| Free Cash Flow Margin | 58.87% | -181.33% | 74.92% | 51.48% | 62.95% | Upgrade
|
| Free Cash Flow Per Share | 1.14 | -2.40 | 0.62 | 0.41 | 0.52 | Upgrade
|
| Levered Free Cash Flow | 23.99 | -67.76 | 5.48 | 4.7 | 13.62 | Upgrade
|
| Unlevered Free Cash Flow | 24.56 | -67.82 | 5.48 | 4.7 | 13.67 | Upgrade
|
| Change in Working Capital | 5.23 | 8.95 | -3.28 | -3.03 | 4.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.